Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | CA12 | O43570 | 3/20 | 0.70 |
| ▸ | CA1 | P00915 | 3/20 | 0.70 |
| ▸ | CA2 | P00918 | 3/20 | 0.70 |
| ▸ | CA3 | P07451 | 3/20 | 0.70 |
| ▸ | CA4 | P22748 | 3/20 | 0.70 |
| ▸ | CA6 | P23280 | 3/20 | 0.70 |
| ▸ | CA5A | P35218 | 3/20 | 0.70 |
| ▸ | CA7 | P43166 | 3/20 | 0.70 |
| ▸ | CA9 | Q16790 | 3/20 | 0.70 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.70 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.70 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.70 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.70 |
| ▸ | DPP4 | P27487 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.70 |
| ▸ | TTR | P02766 | 3/20 | 0.70 |
| ▸ | HPGD | P15428 | 2/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21986902 | 0.85 | IAPP (0.73) | KDM4EHSD17B10CA12CA1CA2 | |
| SCHEMBL21986720 | 0.85 | IAPP (0.73) | KDM4EHSD17B10CA12CA1CA2 | |
| SCHEMBL471934 | 0.85 | KDM4E (0.70) | KDM4EHSD17B10CA12CA1CA2 | |
| SCHEMBL471935 | 0.85 | KDM4E (0.70) | KDM4EHSD17B10CA12CA1CA2 | |
| SCHEMBL584596 | 0.85 | KDM4E (0.58) | KDM4EHSD17B10CA12CA1CA2 | |
| SCHEMBL111230 | 0.85 | KDM4E (0.58) | KDM4EHSD17B10CA12CA1CA2 | |
| SCHEMBL21986709 | 0.84 | PELI1 (0.53) | KDM4EHSD17B10CA12CA1CA2 | |
| SCHEMBL27524820 | 0.84 | KDM4E (0.68) | KDM4EHSD17B10CA12CA1CA2 | |
| SCHEMBL30739974 | 0.84 | PELI1 (0.53) | KDM4EHSD17B10CA12CA1CA2 | |
| SCHEMBL27524817 | 0.84 | KDM4E (0.68) | KDM4EHSD17B10CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11717549-B2 | Steviol glycoside solubility enhancers | CARGILL, INCORPORATED (US) | 2023-08-08 | — | — | US | disclosed |
| US-11701400-B2 | Steviol glycoside compositions with reduced surface tension | CARGILL, INCORPORATED (US) | 2023-07-18 | — | — | US | disclosed |
| US-20170080040-A1 | DECOCTION OF OLIVE LEAVES | EVERGREEN LIFE PRODUCTS S.R.L. (IT) | 2017-03-23 | — | — | US | disclosed |
| US-9512063-B2 | Process for the preparation of advantame | DIVI'S LABORATORIES LIMITED (IN) | 2016-12-06 | — | — | US | disclosed |
| US-20160304439-A1 | PROCESS FOR THE PREPARATION OF ADVANTAME | DIVI'S LABORATORIES LIMITED (IN) | 2016-10-20 | — | — | US | disclosed |
| US-9394555-B2 | Compositions comprising a polypeptide having cellulolytic enhancing activity and a dioxy compound and uses thereof | NOVOZYMES, INC. (US) | 2016-07-19 | — | — | US | disclosed |
| US-20130157317-A1 | Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Dioxy Compound And Uses Thereof | NOVOZYMES, INC. (US) | 2013-06-20 | — | — | US | disclosed |
| US-20070174933-A1 | Altering levels of anti-nutrient factors in plants | HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF AGRICULTURE AND AGRI-FOOD (CA) | 2007-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11701400-B2 | Steviol glycoside compositions with reduced surface tension | STT3A, SIGLEC7, STT3B | KDM4E 4391/4885HSD17B10 473/4885CA12 289/4885 |
| US-11717549-B2 | Steviol glycoside solubility enhancers | SI, TAS2R7, TAS2R31 | KDM4E 3664/4885HSD17B10 827/4885CA12 1617/4885 |
| US-20160304439-A1 | PROCESS FOR THE PREPARATION OF ADVANTAME | TASP1, ASPH, COMT | KDM4E 563/4885HSD17B10 1152/4885CA12 4666/4885 |
| US-20170080040-A1 | DECOCTION OF OLIVE LEAVES | ELOVL5, ALOX5, LIPA | KDM4E 1793/4885HSD17B10 191/4885CA12 3540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.